证券代码:603014 证券简称:威高血净 公告编号:2026-007

Core Viewpoint - The company has successfully redeemed structured deposit products amounting to 235 million RMB, generating a total return of 364,300 RMB from these investments [1][2]. Group 1: Redemption Details - The total redemption amount for the structured deposit products is 235 million RMB [1]. - The structured deposit products were purchased from Weihai Bank and Minsheng Bank, with amounts of 180 million RMB and 55 million RMB respectively [1]. - The total return from the redeemed products is 364,300 RMB [2]. Group 2: Cash Management Status - As of the announcement date, the company has a remaining balance of 240 million RMB in unused raised funds for cash management, which is within the authorized limits set by the board [2]. - The company is authorized to use up to 740 million RMB of temporarily idle raised funds for cash management, ensuring that it does not affect the construction and use of the raised funds [1].

Shandong Weigao Blood Purification Products-证券代码:603014 证券简称:威高血净 公告编号:2026-007 - Reportify